Nuclear Drug for Therapeutic Market size is estimated to be USD 6.5 Billion in 2024 and is expected to reach USD 12.8 Billion by 2033 at a CAGR of 8.2% from 2026 to 2033.
The global nuclear drug for therapeutic market was valued at approximately USD 8.1 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 8.5% from 2023 to 2030. This growth is largely attributed to the increasing adoption of nuclear medicine for the treatment of various diseases such as cancer, cardiovascular diseases, and neurological disorders. The rise in demand for targeted therapy, the advancements in radiopharmaceuticals, and the growing number of diagnostic and therapeutic applications are expected to drive the market forward. In 2022, North America held the largest market share, contributing approximately 40% of the total market revenue due to the presence of advanced healthcare infrastructure, high healthcare spending, and an increasing number of clinical trials for radiopharmaceuticals.
Regionally, Europe accounted for about 25% of the global market share in 2022, supported by increasing awareness and government funding for nuclear drug research. The Asia Pacific region is expected to witness the highest growth rate during the forecast period, with a CAGR of 9.2% from 2023 to 2030. The growing healthcare investments in countries such as China, Japan, and India, alongside rising healthcare infrastructure development and a growing aging population, are key factors driving the regional growth. Latin America and the Middle East & Africa are also expected to experience moderate growth during this period, with expanding healthcare systems and improving access to advanced therapies contributing to the overall market expansion.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=394798&utm_source=Google_site_G_April&utm_medium=227
Â
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=394798&utm_source=Google_site_G_April&utm_medium=227
Growing demand for below applications around the world has had a direct impact on the growth of the Global Nuclear Drug for Therapeutic Market
Radioactive Isotopes
Radiopharmaceuticals
Targeted Radiotherapy Drugs
Cancer Treatment
Cardiovascular Disorders
Neurological Disorders
Thyroid Disorders
Oral
Intravenous
Intramuscular
Subcutaneous
Alpha Radiation Therapy
Beta Radiation Therapy
Gamma Radiation Therapy
Neutron Radiation Therapy
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Research Institutes
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/nuclear-drug-for-therapeutic-market/
1. Introduction of the Global Nuclear Drug for Therapeutic Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Nuclear Drug for Therapeutic Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Nuclear Drug for Therapeutic Market, By Type
6. Global Nuclear Drug for Therapeutic Market, By Application
7. Global Nuclear Drug for Therapeutic Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global Nuclear Drug for Therapeutic Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/